PhD Darja Gramec Skledar

PhD Darja Gramec Skledar
no.: 35432 source: ARIS

researcher – active in research organisation
  darja.gramec_skledarat signsandoz.com
Edit
Research activity

Code Science Field Subfield
1.09.00  Natural sciences and mathematics  Pharmacy   
Bibliography Representative bibliographic units | Personal | COBISS+
source: COBISS
source: SICRIS
Evaluation (metodology)
Evaluation of bibliographic research performance indicators according to ARIS methodology
source: COBISS
source: ARIS
Points
154.37
A''
26.67
A'
141.4
A1/2
152.17
CI10
881
CImax
231
h10
14
A1
0.62
A3
0
Data for the last 5 years (citations for the last 10 years) on November 11, 2025; Data for score A3 calculation refer to period 2020-2024
Data for ARIS tenders ( 21.05.2024 – Target research programmes, archive )
Citations Citations for bibliographic records in COBIB.SI that are linked to records in citation databases
source: WoS source: Scopus source: COBISS
Database Linked records Citations Pure citations Average pure citations
WoS 20  924  841  42.05 
Scopus 19  969  883  46.47 
Education
source: ARIS
Level of education Professional title Study subject Faculty Year
Bachelor's degree  B. Sc.     SI University of Ljubljana, Faculty of Pharmacy 2012 
Doctoral degree  Ph. D.   Biomedicine  SI University of Ljubljana, Faculty of Pharmacy 2018 
Doctoral dissertations and other final papers Show
Obtaining results now
source: COBISS
Employments
source: ARIS
Type of employment Research org. Research group Date of employment Position Role Title
Full time employment (100%, RD:100%)  Lek Pharmaceutical Company d.d.  Raziskovalna skupina Lek (Slovene)  12/9/2019    Researcher  Independent Researcher 
Research projects Legend
source: ARIS
no. Code Title Period Head
1. J1-1717  Development of novel Hsp90 inhibitors with anticancer activity   7/1/2019 - 6/30/2023  PhD Tihomir Tomašić   2,107 
2. N1-0098  Discovery and mechanism of action of novel hEag1 potassium channel lead molecules with anti-cancer activity   1/1/2019 - 12/31/2022  PhD Lucija Peterlin Mašič   1,000 
3. J1-9192  New anticancer leads for emerging cancer target potassium ion channels hEag1 and its validation in lymphoma tumors   7/1/2018 - 6/30/2021  PhD Lucija Peterlin Mašič   2,481 
4. J1-8140  Endokrini in genotoksični potencial inhibitorjev proteinskih kinaz: pomen za tveganja za okolje in zdravje ljudi (Slovene)   5/1/2017 - 4/30/2020  PhD Metka Filipič   4,119 
ARIS research and infrastructure programmes Legend
source: ARIS
no. Code Title Period Head
1. P1-0208  Medicinal chemistry - drug design, synthesis and evaluation   1/1/2015 - 12/31/2021 PhD Stanislav Gobec   6,671 
2. P1-0208  Medicinal chemistry - drug design, synthesis and evaluation   1/1/2009 - 12/31/2014 PhD Danijel Kikelj   6,534 
Confirmation required
Views history
Favourite